SCM
TRIB

Stonehill Capital Management’s Trinity Biotech TRIB Stock Holding History

Stonehill Capital Management’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-248,399
Closed -$507K – 11
2024
Q1 		$507K Sell
248,399
-54,196
-18% -$127K 1.14% 5
2023
Q4 		$649K Hold
302,595
– – 1.28% 7
2023
Q3 		$1.11M Hold
302,595
– – 1.76% 6
2023
Q2 		$1.44M Sell
302,595
-15,000
-5% -$72.6K 0.85% 7
2023
Q1 		$1.49M Sell
317,595
-16,935
-5% -$87.3K 0.77% 8
2022
Q4 		$1.66M Sell
334,530
-79,119
-19% -$479K 1.79% 7
2022
Q3 		$2.21M Sell
413,649
-40,494
-9% -$261K 1.8% 11
2022
Q2 		$2.78M Hold
454,143
– – 1.85% 11
2022
Q1 		$2.41M Buy
454,143
+410,154
+932% +$2.36M 1.12% 12
2021
Q4 		$315K Sell
43,989
-53,798
-55% -$508K 0.07% 22
2021
Q3 		$1.06M Hold
97,787
– – 0.5% 14
2021
Q2 		$1.44M Hold
97,787
– – 0.7% 14
2021
Q1 		$1.84M Sell
97,787
-100,736
-51% -$2.42M 0.86% 10
2020
Q4 		$3.78M Sell
198,523
-74,397
-27% -$1.23M 1.15% 12
2020
Q3 		$2.76M Sell
272,920
-208,527
-43% -$2.41M 1.49% 10
2020
Q2 		$5.25M Sell
481,447
-119,067
-20% -$907K 1.37% 12
2020
Q1 		$3.3M Hold
600,514
– – 1.09% 16
2019
Q4 		$3.1M Buy
600,514
+27,938
+5% +$133K 1.06% 11
2019
Q3 		$3.46M Buy
572,576
+110,385
+24% +$959K 0.94% 11
2019
Q2 		$3.81M Buy
462,191
+130,748
+39% +$1.55M 1.09% 7
2019
Q1 		$4.72M Buy
331,443
+3,674
+1% +$50.5K 1.42% 10
2018
Q4 		$3.75M Buy
327,769
+153,360
+88% +$2.37M 1.75% 15
2018
Q3 		$3.49M Buy
174,409
+26,643
+18% +$579K 1.32% 14
2018
Q2 		$3.69M Hold
147,766
– – 1.45% 10
2018
Q1 		$3.81M Hold
147,766
– – 1.63% 7
2017
Q4 		$3.77M Hold
147,766
– – 1.53% 10
2017
Q3 		$4.14M Hold
147,766
– – 1.65% 8
2017
Q2 		$4.43M Hold
147,766
– – 1.68% 10
2017
Q1 		$4.4M Hold
147,766
– – 1.93% 13
2016
Q4 		$5.11M Buy
+147,766
New +$5.09M 2.59% 11

Other funds holding TRIB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $756M AUM 19.99% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
WCM
Whitefort Capital Management New York $339M AUM 52.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
MAWA
Moss Adams Wealth Advisors Seattle, Washington $1.37B AUM 19.97% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
BCM
Becker Capital Management Portland, Oregon $3.4B AUM 24.68% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Stonehill Capital Management's TRIB Position: Q2 2024 in Review

Stonehill Capital Management sold out of Trinity Biotech (TRIB) in Q2 2024, closing a stake of 248,399 shares — an estimated $507K sold.

Stonehill Capital Management first reported a position in TRIB in Q4 2016 and held it in 30 quarters. The position peaked at $5.25M in Q2 2020. 20 funds tracked by Wall St. Rank hold TRIB as of Q2 2024.

  • Stonehill Capital Management reported no remaining Trinity Biotech position as of Q2 2024 after selling out during the quarter.
  • Stonehill Capital Management sold 248,399 Trinity Biotech shares in Q2 2024, an estimated $507K.
  • Stonehill Capital Management first reported a position in Trinity Biotech in Q4 2016 and held it in 30 quarters.
  • Stonehill Capital Management's Trinity Biotech position peaked at $5.25M in Q2 2020.
  • 20 funds tracked by Wall St. Rank held Trinity Biotech as of Q2 2024.

Based on Stonehill Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.